DAURISMO

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: 766f5bc51ac64357
Drug Approval Canada Name: DAURISMO
Product Name: DAURISMO
Status: Marketed
Status Date: 2020-08-10
Original Market Date: 2020-08-10
Din: 02498480
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01XJ03 GLASDEGIB
Atc Name: l 01 xj 03
Aig Number: 0162218002
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

GLASDEGIB (GLASDEGIB MALEATE)

100 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

766f5bc51ac64357

Type

Standard